Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 304.09M | € 408.47M | € 350.03M | € 22.43M | € 16.64M |
Total Assets | € 2.29B | € 2.35B | € 2.25B | € 1.97B | € 1.99B |
Total Debt | € 844.50M | € 820.34M | € 1.01B | € 1.00B | € 841.21M |
Net Debt | € 540.40M | € 411.87M | € 663.79M | € 979.84M | € 824.57M |
Total Liabilities | € 1.27B | € 1.34B | € 1.36B | € 1.32B | € 1.20B |
Stockholders Equity | € 970.79M | € 961.21M | € 846.00M | € 611.33M | € 740.45M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |